# Nanjing Maohai Biotech Co. · 66-40 · CHINA — FDA import alert red lists: firms subject to detention without physical examination For Nanjing Maohai Biotech Co. · 66-40 · CHINA, import alert is 66-40; import alert name is "Detention Without Physical Examination of Drugs From Firms Which Have Not Met Drug GMPs"; country is CHINA; product is Crude Heparin (Pharmaceutical Necessity) | Heparin Sodium (Anti-Coagulant); product code is 55 R - - 75 Crude Heparin (Pharmaceutic Necessity) | 61 L - - 08 Heparin Sodium (Anti-Coagulant); date published is 10/18/2011; address is 8 Yaxi , Town, Gaochun County , Nanjing, Jiangsu Province CHINA, verified against its source on 2026-09-16. - **Firm:** Nanjing Maohai Biotech Co. _(verified: appears in the quote below)_ - **Import alert:** 66-40 - **Import alert name:** "Detention Without Physical Examination of Drugs From Firms Which Have Not Met Drug GMPs" - **Country:** CHINA _(verified: appears in the quote below)_ - **Address:** 8 Yaxi , Town, Gaochun County , Nanjing, Jiangsu Province CHINA _(verified: appears in the quote below)_ - **Date published:** 10/18/2011 _(verified: appears in the quote below)_ - **Product code:** 55 R - - 75 Crude Heparin (Pharmaceutic Necessity) | 61 L - - 08 Heparin Sodium (Anti-Coagulant) _(verified: each item appears in the quote below)_ - **Product:** Crude Heparin (Pharmaceutical Necessity) | Heparin Sodium (Anti-Coagulant) _(verified: each item appears in the quote below)_ ## What the source says > Nanjing Maohai Biotech Co. Date Published : 10/18/2011 8 Yaxi , Town, Gaochun County , Nanjing, Jiangsu Province CHINA 55 R - - 75 Crude Heparin (Pharmaceutic Necessity) Date Published: 10/18/2011 Desc: Crude Heparin (Pharmaceutical Necessity) 61 L - - 08 Heparin Sodium (Anti-Coagulant) Date Published: 10/18/2011 Desc: Heparin Sodium (Anti-Coagulant) ## Source - https://www.accessdata.fda.gov/cms_ia/importalert_189.html Last verified: 2026-09-16. Review by: 2026-11-15. Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).